Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYL9 |
| Upstream (Parents) |
|---|
| (<<) CYB5R3 → MYL9 |
| (<<) CYR61 → MYL9 |
| (<<) EFEMP2 → MYL9 |
| (<<) IGFBP4 → MYL9 |
| (<<) ITGB1 → MYL9 |
| (<<) TGFB1 → MYL9 |
| (<<) THY1 → MYL9 |
| (<<) TIMP3 → MYL9 |
| (<<) TPM1 → MYL9 |
| Downstream (Children) |
|---|
| MYL9 → ACTA2 (>>) |
| MYL9 → ACTC1 (>>) |
| MYL9 → ACTN1 (>>) |
| MYL9 → ANTXR1 (>>) |
| MYL9 → BMP1 (>>) |
| MYL9 → BZW2 (>>) |
| MYL9 → CCNB1 (>>) |
| MYL9 → CHAF1A (>>) |
| MYL9 → CTGF (>>) |
| MYL9 → EDN1 (>>) |
| MYL9 → FGF1 (>>) |
| MYL9 → FNDC4 (>>) |
| MYL9 → IGFBP7 (>>) |
| MYL9 → ILK (>>) |
| MYL9 → ITGA5 (>>) |
| MYL9 → KLK5 (>>) |
| MYL9 → LOC399959 (>>) |
| MYL9 → MMP2 (>>) |
| MYL9 → MYLK (>>) |
| MYL9 → NEDD4 (>>) |
| MYL9 → PDGFB (>>) |
| MYL9 → PKIB (>>) |
| MYL9 → PLAT (>>) |
| MYL9 → PLAU (>>) |
| MYL9 → PLCD1 (>>) |
| MYL9 → POLR1B (>>) |
| MYL9 → PTRF (>>) |
| MYL9 → RFFL (>>) |
| MYL9 → RHOC (>>) |
| MYL9 → RRAS (>>) |
| MYL9 → SCARF2 (>>) |
| MYL9 → SMTN (>>) |
| MYL9 → SOD3 (>>) |
| MYL9 → SULF2 (>>) |
| MYL9 → SYNPO (>>) |
| MYL9 → TARS (>>) |
| MYL9 → TNFRSF10A (>>) |
| MYL9 → TPM2 (>>) |
| MYL9 → TPM4 (>>) |
| MYL9 → VEGFB (>>) |
